• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射 0.1ml 贝伐单抗后眼结膜下反流和需要行房水穿刺的比较:27 号和 30 号针头。

Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle.

机构信息

Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1573-7. doi: 10.1007/s00417-010-1490-y. Epub 2010 Aug 21.

DOI:10.1007/s00417-010-1490-y
PMID:20730442
Abstract

PURPOSE

Intravitreal injections may lead to a significant elevation of the intraocular pressure (IOP). A paracentesis may become necessary for acute reduction of the IOP in certain cases. The purpose of this study was to determine the frequency of paracentesis performed and the grade of reflux under the conjunctiva after injection of 0.1 ml bevacizumab (1.25 mg), depending on the thickness of the needles used.

METHODS

A retrospective review was undertaken of the surgery reports of 234 consecutive intravitreal bevacizumab injections in 145 eyes of 144 patients within 14 months. In particular, the frequency of paracentesis, the thickness of the needles used (27-gauge versus 30-gauge), the lens status, and a semi-quantitative reflux grade were analysed.

RESULTS

A paracentesis was performed in 78 cases (33%) for acute reduction of the IOP. In the 27-gauge group the frequency was 26% (25 of 96), and in the 30-gauge group 38% (53 of 138) (p = 0.05, independent estimating equation (IEE)). The medians of the semi-quantitative assessment of the reflux grade under the conjunctiva were 2.0 in the 27-gauge group (corresponding to a mild reflux) and 1.0 in the 30-gauge group (corresponding to a minimal reflux, p < 0.001, IEE).

CONCLUSIONS

When using a 30-gauge needle for intravitreal injections, the reflux under the conjunctiva was less than with a 27-gauge needle. However, the use of a 30-gauge needle appeared to be associated with a higher frequency of paracentesis.

摘要

目的

玻璃体内注射可能导致眼内压(IOP)显著升高。在某些情况下,可能需要进行房水穿刺术以迅速降低IOP。本研究旨在确定根据所用针头的厚度,在注射 0.1ml 贝伐单抗(1.25mg)后行房水穿刺术的频率以及结膜下反流的程度。

方法

回顾性分析了 144 例患者的 145 只眼在 14 个月内连续 234 次玻璃体内注射贝伐单抗的手术报告。特别分析了房水穿刺术的频率、所用针头的厚度(27 号与 30 号)、晶状体状态和半定量反流程度。

结果

为了降低 IOP,有 78 例(33%)患者行房水穿刺术。在 27 号组中,房水穿刺术的频率为 26%(96 例中的 25 例),在 30 号组中为 38%(138 例中的 53 例)(p=0.05,独立估计方程(IEE))。27 号组结膜下反流的半定量评估中位数为 2.0(轻度反流),30 号组为 1.0(轻微反流,p<0.001,IEE)。

结论

在进行玻璃体内注射时,使用 30 号针头比使用 27 号针头时结膜下反流更少。然而,使用 30 号针头似乎与房水穿刺术的频率增加有关。

相似文献

1
Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle.玻璃体内注射 0.1ml 贝伐单抗后眼结膜下反流和需要行房水穿刺的比较:27 号和 30 号针头。
Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1573-7. doi: 10.1007/s00417-010-1490-y. Epub 2010 Aug 21.
2
Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits.玻璃体内注射贝伐单抗:在新西兰白兔身上的实验研究。
Arch Ophthalmol. 2010 Jul;128(7):884-7. doi: 10.1001/archophthalmol.2010.139.
3
ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS.玻璃体内注射后针头尺寸、注射后反流与眼压峰值之间的关联
Retina. 2015 Jul;35(7):1401-6. doi: 10.1097/IAE.0000000000000476.
4
Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.预防性降眼压药物对玻璃体内注射后眼压峰值的影响。
Arch Ophthalmol. 2010 Dec;128(12):1523-7. doi: 10.1001/archophthalmol.2010.297.
5
Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.玻璃体内注射抗血管内皮生长因子药物后立即出现的短期眼压变化。
Am J Ophthalmol. 2008 Dec;146(6):930-4.e1. doi: 10.1016/j.ajo.2008.07.007. Epub 2008 Sep 5.
6
Paracentesis before intravitreal injection of bevacizumab.玻璃体内注射贝伐单抗前进行腹腔穿刺术。
Can J Ophthalmol. 2008 Apr;43(2):239; author reply 239-40. doi: 10.3129/i08-033.
7
Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.预防性药物治疗的效果以及玻璃体反流对玻璃体内注射抗VEGF药物后眼压升高的影响。
Eur J Ophthalmol. 2014 Sep-Oct;24(5):771-7. doi: 10.5301/ejo.5000455. Epub 2014 Mar 19.
8
Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.接受单侧玻璃体内抗血管内皮生长因子注射的患者的眼压影响。
Ophthalmology. 2012 Feb;119(2):321-6. doi: 10.1016/j.ophtha.2011.08.011. Epub 2011 Nov 4.
9
Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab.玻璃体内注射曲安奈德、派加他尼和贝伐单抗后眼内压的即刻变化
Eye (Lond). 2009 Jan;23(1):181-5. doi: 10.1038/sj.eye.6702938. Epub 2007 Aug 10.
10
EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.连续前房穿刺对接受玻璃体内抗血管内皮生长因子治疗患者持续眼压升高的影响。
Retina. 2019 Oct;39(10):1959-1964. doi: 10.1097/IAE.0000000000002314.

引用本文的文献

1
Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study.玻璃体内注射2毫克阿柏西普、8毫克阿柏西普和法西单抗后的短期眼压变化:一项前瞻性比较研究。
Br J Ophthalmol. 2025 Apr 22;109(5):600-605. doi: 10.1136/bjo-2024-326053.
2
Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection.经玻璃体腔内注射时行玻璃体液活检相关设备的可行性论证。
PLoS One. 2024 Jan 19;19(1):e0294526. doi: 10.1371/journal.pone.0294526. eCollection 2024.
3
Can intravitreal injections with higher volume cause higher intraocular eye pressure? Considerations for anti-complement injections in normal and glaucomatous eyes.

本文引用的文献

1
Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis).玻璃体内注射0.05毫升雷珠单抗(Lucentis)后的眼压变化过程。
Eur J Ophthalmol. 2010 Jan-Feb;20(1):174-9. doi: 10.1177/112067211002000124.
2
Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.在玻璃体切除术治疗增生性糖尿病视网膜病变前玻璃体内注射贝伐单抗。
Eur J Ophthalmol. 2009 Sep-Oct;19(5):848-52. doi: 10.1177/112067210901900526.
3
Necessity of paracentesis before or after intravitreal injection of bevacizumab.
较高容量的玻璃体内注射会导致更高的眼压吗?正常眼和青光眼眼中抗补体注射的相关考量。
Int J Retina Vitreous. 2023 Dec 14;9(1):80. doi: 10.1186/s40942-023-00517-1.
4
Evaluation of intraocular pressure change and anterior segment parameters after intravitreal bevacizumab injection - Cannula size matters.玻璃体内注射贝伐单抗后眼压变化及眼前节参数评估——套管尺寸很重要。
Saudi J Ophthalmol. 2021 Jul 29;34(4):247-250. doi: 10.4103/1319-4534.322606. eCollection 2020 Oct-Dec.
5
Vitreous Reflux Frequency and Intraocular Pressure After First-Time Intravitreal Aflibercept Injections: Comparison of 30- and 32-Gauge Needles.首次玻璃体内注射阿柏西普后的玻璃体反流频率和眼压:30号与32号针头的比较
Clin Ophthalmol. 2020 Mar 3;14:625-634. doi: 10.2147/OPTH.S243370. eCollection 2020.
6
Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects.观察性试验中玻璃体内注射时的前房穿刺术:有效性、安全性及影响
Int J Retina Vitreous. 2019 Mar 6;5:8. doi: 10.1186/s40942-019-0157-z. eCollection 2019.
7
Short-term intraocular pressure changes after intravitreal injection of bevacizumab for retinopathy of prematurity.玻璃体内注射贝伐单抗治疗早产儿视网膜病变后的短期眼压变化
Jpn J Ophthalmol. 2019 May;63(3):262-268. doi: 10.1007/s10384-019-00661-y. Epub 2019 Mar 1.
8
Immediate effect of intravitreal injection of bevacizumab on intraocular pressure.玻璃体内注射贝伐单抗对眼压的即时影响。
Clin Ophthalmol. 2014 Jul 23;8:1383-8. doi: 10.2147/OPTH.S64721. eCollection 2014.
9
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review.玻璃体内注射贝伐单抗单药治疗成人眼科疾病的安全性:系统评价
BMJ Open. 2014 Jul 17;4(7):e005244. doi: 10.1136/bmjopen-2014-005244.
玻璃体内注射贝伐单抗之前或之后进行腹腔穿刺术的必要性。
Arch Ophthalmol. 2008 Sep;126(9):1314-5; author reply 1315. doi: 10.1001/archopht.126.9.1314.
4
[Chances and risks of anti-VEGF therapy].[抗血管内皮生长因子治疗的机遇与风险]
Klin Monbl Augenheilkd. 2008 Sep;225(9):770-8. doi: 10.1055/s-2008-1027487.
5
Reflux after intravitreal injection of bevacizumab.玻璃体内注射贝伐单抗后的反流
Ophthalmology. 2008 Jul;115(7):1270; author reply 1271. doi: 10.1016/j.ophtha.2008.02.021.
6
Effect of repeated IOP challenge on rat retinal function.重复眼压挑战对大鼠视网膜功能的影响。
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3026-34. doi: 10.1167/iovs.07-1628. Epub 2008 Mar 7.
7
Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab.玻璃体内注射曲安奈德、派加他尼和贝伐单抗后眼内压的即刻变化
Eye (Lond). 2009 Jan;23(1):181-5. doi: 10.1038/sj.eye.6702938. Epub 2007 Aug 10.
8
Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model.玻璃体内注射及容积变化对眼压的影响:临床结果与生物力学模型
Acta Ophthalmol Scand. 2007 Nov;85(7):777-81. doi: 10.1111/j.1600-0420.2007.00939.x. Epub 2007 Jun 16.
9
Tunneled scleral incision to prevent vitreal reflux after intravitreal injection.隧道式巩膜切口预防玻璃体内注射后玻璃体反流。
Am J Ophthalmol. 2007 Jun;143(6):1035-7. doi: 10.1016/j.ajo.2007.01.035.
10
The rate of functional recovery from acute IOP elevation.急性眼压升高后的功能恢复率。
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4872-80. doi: 10.1167/iovs.06-0590.